Novacyt(GB:NCYT)
GBXÂ 36.20-0.90 (-2.43%)
GB:NCYT
Novacyt financials statements
GBXÂ 36.20
At close:-0.90 (-2.43%)
Novacyt (NCYT) Ratios
9 Followers
Novacyt Ratios
GB:NCYT's free cash flow for Q2 2026 was €-4.58M. For the 2026 fiscal year, GB:NCYT's free cash flow was decreased by €-123.76K and operating cash flow was €-4.46M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 4.74 | 6.33 | 2.92 | 5.25 | 4.08 |
| Quick Ratio | 4.31 | 5.97 | 2.82 | 5.13 | 3.79 |
| Cash Ratio | 3.28 | 4.90 | 1.49 | 3.59 | 2.62 |
| Solvency Ratio | -1.08 | -1.60 | -0.40 | -0.77 | -0.18 |
| Operating Cash Flow Ratio | -1.50 | -1.47 | -0.85 | -0.57 | 0.40 |
| Short-Term Operating Cash Flow Coverage | -10.24 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | € 10.72M | € 16.62M | € 39.88M | € 101.55M | € 116.90M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.26 | 0.17 | 0.10 | 0.01 | 0.01 |
| Debt-to-Equity Ratio | 0.45 | 0.25 | 0.16 | 0.01 | 0.01 |
| Debt-to-Capital Ratio | 0.31 | 0.20 | 0.14 | 0.01 | 0.01 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.73 | 1.48 | 1.53 | 1.22 | 1.30 |
| Debt Service Coverage Ratio | -2.77 | -2.06 | -25.62 | -28.27 | -17.14 |
| Interest Coverage Ratio | -19.39 | -7.29 | -43.28 | -33.95 | -5.72 |
| Debt to Market Cap | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.16 | 0.24 | 0.20 | 0.02 | 0.03 |
| Net Debt to EBITDA | 1.06 | 1.65 | 1.66 | 7.37 | 23.80 |
| Profitability Margins | |||||
| Gross Profit Margin | 38.65% | 163.39% | 32.21% | 27.31% | 30.99% |
| EBIT Margin | -64.58% | -84.87% | -240.83% | -93.13% | -5.78% |
| EBITDA Margin | -40.25% | -57.41% | -157.55% | -55.50% | -4.38% |
| Operating Profit Margin | -64.58% | -190.23% | -254.91% | -78.91% | -1.43% |
| Pretax Profit Margin | -136.53% | -200.87% | -246.72% | -95.31% | -10.26% |
| Net Profit Margin | -114.25% | -212.73% | -244.34% | -105.52% | -10.16% |
| Continuous Operations Profit Margin | -117.09% | -197.14% | -240.09% | -105.52% | -6.27% |
| Net Income Per EBT | 83.68% | 105.90% | 99.03% | 110.71% | 98.97% |
| EBT Per EBIT | 211.43% | 105.59% | 96.79% | 120.79% | 719.02% |
| Return on Assets (ROA) | -57.87% | -59.12% | -21.14% | -15.76% | -5.30% |
| Return on Equity (ROE) | -99.88% | -87.21% | -32.43% | -19.27% | -6.86% |
| Return on Capital Employed (ROCE) | -38.25% | -57.98% | -28.31% | -14.23% | -0.94% |
| Return on Invested Capital (ROIC) | -31.25% | -55.81% | -27.24% | -14.16% | -0.93% |
| Return on Tangible Assets | -63.42% | -82.87% | -27.70% | -16.93% | -5.77% |
| Earnings Yield | -84.41% | -118.67% | -64.84% | -28.92% | -3.74% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.07 | 5.29 | 0.42 | 0.00 | 2.67 |
| Payables Turnover | 9.51 | -26.94 | 3.40 | 55.01 | 48.50 |
| Inventory Turnover | 4.94 | -5.48 | 2.60 | 5.05 | 5.77 |
| Fixed Asset Turnover | 2.27 | 1.83 | 0.76 | 6.43 | 15.01 |
| Asset Turnover | 0.51 | 0.28 | 0.09 | 0.15 | 0.52 |
| Working Capital Turnover Ratio | 0.74 | 0.44 | 0.14 | 0.19 | 0.76 |
| Cash Conversion Cycle | 125.12 | 16.04 | 899.71 | 65.61 | 192.45 |
| Days of Sales Outstanding | 89.58 | 69.04 | 866.65 | 0.00 | 136.69 |
| Days of Inventory Outstanding | 73.91 | -66.55 | 140.53 | 72.24 | 63.28 |
| Days of Payables Outstanding | 38.37 | -13.55 | 107.47 | 6.63 | 7.53 |
| Operating Cycle | 163.49 | 2.49 | 1007.18 | 72.24 | 199.98 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.12 | -0.13 | -0.35 | -0.19 | 0.22 |
| Free Cash Flow Per Share | -0.13 | -0.16 | -0.36 | -0.20 | 0.16 |
| Dividend Paid and CapEx Coverage Ratio | -32.08 | -4.92 | -37.24 | -33.00 | 3.83 |
| Capital Expenditure Coverage Ratio | -32.08 | -4.92 | -37.24 | -33.00 | 3.83 |
| Operating Cash Flow Coverage Ratio | -0.84 | -0.77 | -1.82 | -15.74 | 8.39 |
| Operating Cash Flow to Sales Ratio | -0.43 | -0.47 | -2.16 | -0.65 | 0.16 |
| Free Cash Flow Yield | -32.71% | -31.29% | -58.81% | -18.42% | 4.45% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -1.18 | -0.84 | -1.54 | -3.46 | -26.75 |
| Price-to-Sales (P/S) Ratio | 1.35 | 1.79 | 3.77 | 3.65 | 2.72 |
| Price-to-Book (P/B) Ratio | 1.18 | 0.73 | 0.50 | 0.67 | 1.83 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -3.06 | -3.20 | -1.70 | -5.43 | 22.45 |
| Price-to-Operating Cash Flow Ratio | -3.15 | -3.85 | -1.75 | -5.59 | 16.58 |
| Price-to-Earnings Growth (PEG) Ratio | 0.03 | -0.02 | -0.05 | -0.03 | 0.25 |
| Enterprise Value Multiple | -2.30 | -1.47 | -0.73 | 0.80 | -38.20 |
| Enterprise Value | 18.92M | 16.61M | 13.29M | -9.33M | 160.32M |
| EV to EBITDA | -2.30 | -1.47 | -0.73 | 0.80 | -38.20 |
| EV to Sales | 0.93 | 0.85 | 1.15 | -0.44 | 1.67 |
| EV to Free Cash Flow | -2.10 | -1.51 | -0.52 | 0.66 | 13.83 |
| EV to Operating Cash Flow | -2.16 | -1.82 | -0.53 | 0.68 | 10.22 |
| Tangible Book Value Per Share | 0.28 | 0.39 | 0.79 | 1.49 | 1.79 |
| Shareholders’ Equity Per Share | 0.33 | 0.68 | 1.24 | 1.63 | 2.01 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.14 | 0.02 | 0.03 | -0.11 | 0.01 |
| Revenue Per Share | 0.29 | 0.28 | 0.16 | 0.30 | 1.36 |
| Net Income Per Share | -0.33 | -0.59 | -0.40 | -0.31 | -0.14 |
| Tax Burden | 0.84 | 1.06 | 0.99 | 1.11 | 0.99 |
| Interest Burden | 2.11 | 2.37 | 1.02 | 1.02 | 1.77 |
| Research & Development to Revenue | 0.21 | 0.14 | 0.28 | 0.24 | 0.05 |
| SG&A to Revenue | 0.27 | 2.12 | 0.42 | 0.23 | 0.07 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.37 | 0.22 | 0.88 | 0.53 | -1.61 |
Currency in EUR
